Free Trial

Insider Buying: Xylem (NYSE:XYL) Director Buys 1,210 Shares of Stock

Xylem logo with Business Services background
Image from MarketBeat Media, LLC.

Key Points

  • Director Jerome Peribere bought 1,210 shares at an average price of $116.61 (total $141,098), raising his direct holdings to 27,209 shares — a 4.65% increase in his position.
  • Xylem's Board authorized a $1.5 billion share buyback (up to 4.8% of outstanding shares) and the company raised its quarterly dividend to $0.43 ($1.72 annualized, ~1.5% yield).
  • In Q1 Xylem reported $1.12 EPS vs. $1.09 expected and revenue of $2.13B (+2.7% YoY); the company set FY2026 guidance of $5.35–$5.60 EPS, near the sell-side consensus of ~5.51.
  • MarketBeat previews top five stocks to own in June.

Xylem Inc. (NYSE:XYL - Get Free Report) Director Jerome Peribere acquired 1,210 shares of the firm's stock in a transaction dated Monday, May 4th. The shares were purchased at an average cost of $116.61 per share, for a total transaction of $141,098.10. Following the acquisition, the director directly owned 27,209 shares in the company, valued at $3,172,841.49. This represents a 4.65% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

Xylem Stock Performance

Shares of NYSE:XYL traded down $0.43 during trading on Monday, hitting $114.94. 1,637,552 shares of the stock were exchanged, compared to its average volume of 2,041,589. Xylem Inc. has a 1-year low of $114.15 and a 1-year high of $154.27. The company has a market capitalization of $27.32 billion, a price-to-earnings ratio of 28.59, a price-to-earnings-growth ratio of 1.64 and a beta of 1.08. The company's fifty day simple moving average is $123.29 and its 200-day simple moving average is $134.70. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.10 and a current ratio of 1.46.

Xylem (NYSE:XYL - Get Free Report) last announced its quarterly earnings data on Tuesday, April 28th. The industrial products company reported $1.12 earnings per share for the quarter, topping the consensus estimate of $1.09 by $0.03. Xylem had a return on equity of 11.26% and a net margin of 10.79%.The company had revenue of $2.13 billion for the quarter, compared to analyst estimates of $2.11 billion. During the same quarter last year, the firm earned $1.03 EPS. Xylem's revenue for the quarter was up 2.7% compared to the same quarter last year. Xylem has set its FY 2026 guidance at 5.350-5.600 EPS. Sell-side analysts expect that Xylem Inc. will post 5.51 EPS for the current fiscal year.

Xylem announced that its Board of Directors has authorized a stock buyback program on Wednesday, February 25th that permits the company to buyback $1.50 billion in outstanding shares. This buyback authorization permits the industrial products company to buy up to 4.8% of its shares through open market purchases. Shares buyback programs are often a sign that the company's management believes its shares are undervalued.

Xylem Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 24th. Stockholders of record on Tuesday, February 24th were issued a dividend of $0.43 per share. This represents a $1.72 annualized dividend and a dividend yield of 1.5%. The ex-dividend date of this dividend was Tuesday, February 24th. This is a boost from Xylem's previous quarterly dividend of $0.40. Xylem's payout ratio is 42.79%.

Analysts Set New Price Targets

XYL has been the topic of several recent analyst reports. Royal Bank Of Canada decreased their price target on Xylem from $176.00 to $162.00 and set an "outperform" rating on the stock in a research note on Wednesday, February 11th. JPMorgan Chase & Co. decreased their price target on Xylem from $170.00 to $160.00 and set an "overweight" rating on the stock in a research note on Thursday, April 16th. Oppenheimer decreased their price target on Xylem from $160.00 to $158.00 and set an "outperform" rating on the stock in a research note on Wednesday, April 29th. Jefferies Financial Group reaffirmed a "hold" rating and issued a $130.00 price target (down from $140.00) on shares of Xylem in a research note on Tuesday, March 31st. Finally, Citigroup decreased their price target on Xylem from $174.00 to $168.00 and set a "buy" rating on the stock in a research note on Wednesday, April 29th. Seven investment analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $152.77.

Check Out Our Latest Report on Xylem

Hedge Funds Weigh In On Xylem

A number of institutional investors and hedge funds have recently bought and sold shares of the business. J. Safra Sarasin Holding AG boosted its stake in Xylem by 5.6% in the first quarter. J. Safra Sarasin Holding AG now owns 332,132 shares of the industrial products company's stock worth $39,632,000 after purchasing an additional 17,640 shares in the last quarter. LGT Fund Management Co Ltd. boosted its stake in Xylem by 25.0% in the first quarter. LGT Fund Management Co Ltd. now owns 20,038 shares of the industrial products company's stock worth $2,395,000 after purchasing an additional 4,011 shares in the last quarter. Global Assets Advisory LLC acquired a new position in Xylem in the first quarter worth $40,000. UNIVEST FINANCIAL Corp acquired a new position in Xylem in the first quarter worth $908,000. Finally, Welch & Forbes LLC boosted its stake in Xylem by 3.0% in the first quarter. Welch & Forbes LLC now owns 413,855 shares of the industrial products company's stock worth $49,456,000 after purchasing an additional 12,023 shares in the last quarter. Institutional investors and hedge funds own 87.96% of the company's stock.

About Xylem

(Get Free Report)

Xylem Inc NYSE: XYL is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.

Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Xylem Right Now?

Before you consider Xylem, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.

While Xylem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 7 Hottest IPOs On Wall Street’s 2026 Watchlist Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines